COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03524261
Recruitment Status : Withdrawn (No participants enrolled)
First Posted : May 14, 2018
Last Update Posted : October 19, 2020
Benhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Information provided by (Responsible Party):
Fuda Cancer Hospital, Guangzhou

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : April 5, 2020
Actual Study Completion Date : July 5, 2020